Organon Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . Organon Co
7XP Stock   6.19  0.21  3.51%   
Organon's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Organon's valuation are provided below:
Gross Profit
3.4 B
Profit Margin
0.0301
Market Capitalization
1.6 B
Enterprise Value Revenue
1.6074
Revenue
6.2 B
There are over seventy available trending fundamental ratios for Organon, which can be analyzed over time and compared to other ratios. Active traders should verify all of Organon recent fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Organon Total Revenue

6.01 Billion

Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Interest Expense of 627.9 M, Ebit of 2.2 B or Net Income Applicable To Common Shares of 1.5 B, as well as many indicators such as . Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
  
This module can also supplement various Organon Technical models . Check out the analysis of Organon Correlation against competitors.

Organon Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities202.1 M205.2 M279.4 M
Slightly volatile
Total Current Liabilities2.6 B3.1 B2 B
Slightly volatile
Other Liabilities239.4 M252 M1.7 B
Slightly volatile
Accounts Payable909.4 M1.3 B607.9 M
Slightly volatile
Other Assets447.5 M485.1 M618.8 M
Slightly volatile
Net Receivables1.2 B1.2 B1.5 B
Slightly volatile
Inventory1.2 B1.5 B1.1 B
Slightly volatile
Other Current Assets671.4 M894.6 M847.6 M
Pretty Stable
Total Current Assets4.4 B5 B3.9 B
Slightly volatile
Common Stock2.6 M2.7 M4.7 B
Slightly volatile
Property Plant Equipment1.1 B1.4 B883.9 M
Slightly volatile
Total Assets12.4 B15.1 B11.2 B
Slightly volatile
Property Plant And Equipment Net1.1 B1.3 B857.1 M
Slightly volatile
Cash665.5 M776.2 M467.2 M
Slightly volatile
Non Current Assets Total8 B10.1 B7.1 B
Slightly volatile
Non Currrent Assets Other1.1 B1.7 B898.3 M
Slightly volatile
Long Term Debt7.9 B10.2 B3.7 B
Slightly volatile
Good Will5.1 B5.4 B4.7 B
Slightly volatile
Common Stock Shares Outstanding280 M296.2 M257.7 M
Slightly volatile
Non Current Liabilities Total9.2 B11.4 B5.3 B
Slightly volatile
Total Liabilities11.7 B14.5 B7.1 B
Slightly volatile
Property Plant And Equipment Gross2.1 B2.6 B1.7 B
Slightly volatile
Short and Long Term Debt17.1 M18 M103.5 M
Very volatile
Non Current Liabilities Other835.3 M879.3 M2 B
Pretty Stable
Net Working Capital1.4 B1.5 B2.2 B
Slightly volatile
Intangible Assets1.7 B1.6 B751.4 M
Slightly volatile
Net Debt7.5 B9.4 B3.8 B
Slightly volatile

Organon Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
EBIT2.2 B1.5 B2.7 B
Slightly volatile
Net Income Applicable To Common Shares1.5 B825.3 M1.7 B
Slightly volatile
Income Tax Expense175.3 M184.5 M764.6 M
Slightly volatile
Selling General Administrative1.4 B1.6 B1.9 B
Slightly volatile
Total Revenue6 B5.8 B8.4 B
Slightly volatile
Gross Profit3.5 B3.3 B4.6 B
Slightly volatile
Operating Income1.8 B1.3 B2.4 B
Slightly volatile
Net Income From Continuing Ops1.3 B777.6 M1.8 B
Slightly volatile
Research Development457.6 M539.4 M401.7 M
Slightly volatile
EBITDA2.6 B1.4 B3.3 B
Slightly volatile
Cost Of Revenue2.5 B2.4 B3.8 B
Slightly volatile
Total Operating Expenses4.2 B4.4 B6 B
Slightly volatile
Reconciled Depreciation354.7 M249.3 M1 B
Slightly volatile
Income Before Tax690 M726.3 M2.1 B
Slightly volatile
Net Income1.3 B777.6 M1.8 B
Slightly volatile

Organon Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation498.2 M249.3 M1.1 B
Slightly volatile
Capital Expenditures208.7 M403.6 M160.7 M
Slightly volatile
Total Cash From Operating Activities802.8 M845.1 M2.5 B
Slightly volatile
Net Income1.3 B777.6 M1.7 B
Slightly volatile
End Period Cash Flow533 M776.2 M622.5 M
Slightly volatile
Free Cash Flow502.7 M529.2 M2.4 B
Slightly volatile
Begin Period Cash Flow523.8 M797 M636.6 M
Slightly volatile
Other Non Cash Items93.7 M152.9 M57.9 M
Slightly volatile
Stock Based Compensation79 M120.8 M58.8 M
Slightly volatile

Organon Fundamental Market Drivers

About Organon Financial Statements

Organon stakeholders use historical fundamental indicators, such as Organon's revenue or net income, to determine how well the company is positioned to perform in the future. Although Organon investors may analyze each financial statement separately, they are all interrelated. For example, changes in Organon's assets and liabilities are reflected in the revenues and expenses on Organon's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Organon Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue5.8 B6 B
Cost Of Revenue2.4 B2.5 B

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
How To Invest In Organon
Details
Is Organon Stock a good investment?
Details
What is Organon's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Organon Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Organon's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Organon represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Organon's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY